Asia markets to rise in muted session as lots of marketplaces shut for holiday

Asia markets to rise in muted session as lots of marketplaces shut for holiday


Aerial check out of the money town of Seoul in South Korea, found at sunset.

Tobiasjo | E+ | Getty Pictures

Shares in Tokyo and Seoul are set to trade bigger on Friday in a muted session as most marketplaces are closed for a holiday in the broader Asia-Pacific area.

The Nikkei futures deal in Chicago was at 27,620 even though its counterpart in Osaka was at 27,556 against the Nikkei 225‘s very last close at 27,472.63. South Korea’s Kospi 200 futures also pointed to a better open.

Australia, Hong Kong, mainland China, Singapore and India are shut.



Supply

Fed officials split on where interest rates should go, minutes say
World

Fed officials split on where interest rates should go, minutes say

Divided Federal Reserve officials at their January meeting indicated that further interest rate cuts should be paused for now but could resume later in the year only if inflation cooperates. While the decision to hold the central bank’s benchmark rate steady mostly was met with approval, the path ahead appeared less certain, with members conflicted […]

Read More
Microsoft’s Brad Smith says U.S. tech should ‘worry a little’ about Chinese firms’ government subsidies
World

Microsoft’s Brad Smith says U.S. tech should ‘worry a little’ about Chinese firms’ government subsidies

Microsoft President Brad Smith speaks at a press conference at the Representation of the State of North Rhine-Westphalia about future visions for the development and application of artificial intelligence in education in NRW in Berlin on June 4, 2025. Soeren Stache | Picture Alliance | Getty Images American tech companies should “worry a little bit” […]

Read More
FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal
World

FDA agrees to review Moderna’s mRNA flu vaccine application in a reversal

A researcher works in the lab at the Moderna headquarters in Cambridge, Massachusetts, March 26, 2024. Adam Glanzman | Bloomberg | Getty Images Moderna said on Wednesday the Food and Drug Administration has agreed to review its experimental mRNA flu shot, reversing the agency’s earlier decision to refuse to accept the application in a move […]

Read More